Mojca Lunder

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

Mojca Lunder, Miodrag Janić, M. Japelj et al. · Cardiovascular Diabetology · 2018 · 92 citations · Full text

Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males – a pilot study

Mojca Lunder, Miodrag Janić, Sara Habjan et al. · Atherosclerosis · 2011 · 39 citations

Vascular Disease, Cardiovascular Disease, Middle-aged Males +8

The effects of low-dose fluvastatin and valsartan combination on arterial function: A randomized clinical trial

Mojca Lunder, Miodrag Janić, Borut Jug et al. · European Journal of Internal Medicine · 2011 · 37 citations

Cardiovascular Disease, Medicine, Antihypertensive Therapy +8

Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections

Špela Volčanšek, Mojca Lunder, Andrej Janež · Diabetes Technology & Therapeutics · 2019 · 27 citations

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”

Miodrag Janić, Mojca Lunder, Srdjan Novaković et al. · International Journal of Molecular Sciences · 2019 · 24 citations · Full text